2
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Influence of Specific Anti-Salmon Calcitonin Antibodies on Biological Effectiveness of Nasal Salmon Calcitonin in Paget's Disease of Bone

, , , , , , , & show all
Pages 83-86 | Received 30 Jan 1989, Published online: 12 Jul 2009

References

  • Niall H D, Keutmann H T, Copp D H, Potts J T. Amino acid sequence of salmon ultimobranchial calcitonin. Proc Natl Acad Sci 1969; 64: 771–8
  • Hosking D J, Denton L B, Cadge B, Martin T J. Functional significance of antibody formation after long-term salmon calcitonin therapy. Clin Endocrin 1979; 10: 243–52
  • Singer F R, Aldred J C, Neer R M, Krane S M, Potts J T, Bloch K J. An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest 1972; 51: 2331–8
  • Reginster J Y, Franchimont P. Side effect of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin Exp Rheum 1985; 3: 155–7
  • Reginster J Y, Denis D, Albert A, Deroisy R, Lecart M P, Fontaine M A, Lambelin P, Franchimont P. 1-Year Controlled Randomization Trial of Prevention of Early Postmenopausal Bone Loss by Intranasal Calcitonin. Lancet 1987; ii: 1481–3
  • Trayser K A, Seligson D. A new kinetic method for the enzyme analysis suitable for automation. Clin Chem 1969; 15: 452
  • Greenwood F C, Hunter W M, Glover J S. Preparation of iodine-131 labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–23
  • Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Science 1949; 751: 660–72
  • Zerbe G O. Randomization analysis of the completely randomized design extended to growth and response curves. J Amer Statist Ass 1979; 74: 215–21
  • Reginster J Y, Jeugmans-Huynen A M, Albert A, Denis D, Franchimont P. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray. J Bone Min Res 1988; 3: 249–52
  • Reginster J Y, Denis D, Albert A, Franchimont P. Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects. Bone and Mineral 1987; 2: 133–40
  • Singer F R, Fredericks R S, Minkin C. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired resistance. Arthritis Rheum 1980; 23: 1148–53
  • Muff R, Levy F, Dotty-Sigrist S, Dambacher M A, Fisher J A. Formation of neutralising antibodies to synthetic salmon calcitonin during treatment of Paget's disease. J Bone Miner Res 1988; 3SI: A96

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.